ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 53 filers reported holding ADC THERAPEUTICS SA in Q1 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,488 | -58.3% | 19,496 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $41,916 | +10.3% | 19,496 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $38,017 | -49.2% | 19,496 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $74,865 | -20.4% | 19,496 | -0.0% | 0.00% | -50.0% |
| Q3 2022 | $94,000 | -39.4% | 19,502 | +0.0% | 0.00% | -20.0% |
| Q2 2022 | $155,000 | -45.8% | 19,497 | +0.1% | 0.01% | -54.5% |
| Q1 2022 | $286,000 | -27.4% | 19,469 | -0.2% | 0.01% | -31.2% |
| Q4 2021 | $394,000 | -25.7% | 19,505 | -0.0% | 0.02% | -33.3% |
| Q3 2021 | $530,000 | +11.6% | 19,514 | +0.0% | 0.02% | +9.1% |
| Q2 2021 | $475,000 | -0.2% | 19,507 | +0.0% | 0.02% | -12.0% |
| Q1 2021 | $476,000 | – | 19,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |